Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors

RecruitingOBSERVATIONAL
Enrollment

375

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2031

Conditions
Portal HypertensionCirrhosisVarices, Esophageal
Trial Locations (8)

Unknown

NOT_YET_RECRUITING

Royal Prince Alfred Hospital, Sydney

NOT_YET_RECRUITING

Southern Medical University, Guangzhou

NOT_YET_RECRUITING

Ruijing Hospital, Shanghai

RECRUITING

Prince of Wales Hospital, Hong Kong

NOT_YET_RECRUITING

AIG Hospital, Hyderabad

NOT_YET_RECRUITING

Institute of Liver and Biliary Sciences, New Delhi

NOT_YET_RECRUITING

Changi General Hospital, Singapore

NOT_YET_RECRUITING

National University Hospital, Singapore, Singapore

All Listed Sponsors
collaborator

Southern Medical University, China

OTHER

collaborator

Ruijin Hospital North Shanghai Jiao Tong University School of Medicine

UNKNOWN

collaborator

National University Hospital, Singapore

OTHER

collaborator

Changi General Hospital

OTHER

collaborator

Institute of Liver and Biliary Sciences, India

OTHER

collaborator

Royal Prince Alfred Hospital, Sydney, Australia

OTHER

collaborator

Asian Institute of Gastroenterology, India

OTHER

lead

Chinese University of Hong Kong

OTHER